Vi Government Hospital and Health Facilities Corp

Vi Government Hospital and Health Facilities Corp was paid $23.63M by Medicaid between Jan 2018 and Nov 2024, across 215 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 28% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	40,426	$2.93M
2019	64,980	$3.80M
2020	61,411	$3.22M
2021	68,609	$3.84M
2022	70,704	$4.14M
2023	70,149	$3.58M
2024incomplete	49,293	$2.11M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
36415	Collection of venous blood by venipuncture	28%	27,390	23,637	$6.70M
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	10%	12,794	1,153	$2.38M
99281	Emergency department visit for the evaluation and management, self-limited or minor	6.2%	7,375	6,223	$1.47M
99282	Emergency department visit for the evaluation and management, low to moderate severity	6.0%	28,670	19,585	$1.42M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	3.7%	4,462	4,027	$867K
81003		3.0%	15,688	14,175	$720K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	3.0%	5,620	1,584	$704K
Q9962	High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml	2.9%	2,534	2,381	$697K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.6%	1,793	1,260	$605K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	2.4%	5,611	4,659	$577K
77067	Screening mammography, bilateral, including computer-aided detection	2.3%	1,818	1,741	$555K
90999	Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient	2.3%	23,669	1,856	$549K

203 more codes

87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.2%	3,322	$522K
80053	Comprehensive metabolic panel	1.6%	14,489	$381K
J2501	Injection, paricalcitol, 1 mcg	1.5%	16,933	$358K
71046	Radiologic examination, chest; 2 views	1.5%	3,308	$351K
J0606	Injection, etelcalcetide, 0.1 mg	1.2%	2,254	$292K
87070		1.2%	2,325	$279K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.2%	1,148	$274K
70450	Computed tomography, head or brain; without contrast material	1.1%	2,298	$248K
J1644	Injection, heparin sodium, per 1000 units	1.0%	3,180	$246K
99283	Emergency room visit (moderate)	<1%	22,094	$227K
88313		<1%	2,129	$208K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	790	$199K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	551	$164K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	22,326	$161K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,040	$161K
84703		<1%	2,955	$158K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	533	$156K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,725	$139K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,239	$133K
G0378	Hospital observation service, per hour	<1%	4,162	$130K
71045	Radiologic examination, chest; single view	<1%	2,157	$102K
88142		<1%	1,518	$84K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,326	$82K
99284	Emergency room visit (serious)	<1%	7,218	$80K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	1,796	$71K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	4,194	$63K
82948		<1%	1,062	$54K
87088		<1%	5,741	$52K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,834	$41K
99001		<1%	8,661	$38K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	3,645	$38K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	279	$35K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	551	$33K
99285	Emergency room visit (most serious)	<1%	1,516	$29K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,911	$28K
87177		<1%	1,724	$27K
76801		<1%	100	$27K
73030		<1%	148	$24K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,038	$24K
99204	Doctor's office visit, new patient (more involved)	<1%	75	$24K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	82	$23K
80061	Lipid panel	<1%	5,564	$21K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	5,176	$21K
80048	Basic metabolic panel (calcium, ionized)	<1%	3,340	$20K
96376		<1%	246	$20K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	49	$19K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,560	$18K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	996	$17K
84443	Thyroid stimulating hormone (TSH)	<1%	4,586	$16K
90656		<1%	101	$16K
29581		<1%	487	$16K
72100		<1%	93	$14K
93000		<1%	426	$14K
J1170	Injection, hydromorphone, up to 4 mg	<1%	826	$14K
96361	Intravenous infusion, hydration; each additional hour	<1%	2,688	$13K
85014		<1%	759	$13K
73630		<1%	106	$13K
86850		<1%	1,199	$13K
88141		<1%	215	$12K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,837	$12K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	501	$12K
82485		<1%	2,641	$11K
94664		<1%	472	$10K
82310		<1%	1,150	$10K
82272		<1%	281	$9K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,857	$9K
87807		<1%	543	$9K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	44	$9K
87077		<1%	3,119	$9K
82553		<1%	1,046	$9K
73562		<1%	65	$9K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	3,750	$9K
84484		<1%	2,609	$8K
84702		<1%	932	$8K
73610		<1%	32	$8K
88108		<1%	237	$8K
J0735	Injection, clonidine hydrochloride, 1 mg	<1%	64	$7K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	379	$7K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,225	$6K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	273	$6K
90837	Psychotherapy session, about an hour	<1%	34	$6K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,331	$5K
G0008	Administration of influenza virus vaccine	<1%	50	$5K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	14	$5K
72125	Computed tomography, cervical spine; without contrast material	<1%	41	$5K
85610		<1%	1,615	$5K
87481		<1%	36	$5K
90792	Psychiatric diagnostic evaluation with medical services	<1%	28	$5K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,537	$4K
82803		<1%	591	$4K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	14	$4K
76819	Fetal biophysical profile; without non-stress testing	<1%	34	$4K
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	680	$4K
87040		<1%	264	$4K
86703		<1%	1,338	$3K
84153		<1%	770	$3K
82465		<1%	1,717	$3K
84550		<1%	1,665	$3K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	279	$3K
97602		<1%	155	$3K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,917	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	100	$3K
83880		<1%	607	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	228	$3K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	45	$3K
87186		<1%	2,556	$3K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	102	$3K
84439		<1%	1,606	$3K
86900		<1%	1,538	$3K
90714		<1%	245	$2K
83550		<1%	430	$2K
J2060	Injection, lorazepam, 2 mg	<1%	133	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	134	$2K
J7030	Infusion, normal saline solution , 1000 cc	<1%	42	$2K
83735		<1%	1,260	$2K
86592		<1%	1,520	$2K
83690		<1%	1,798	$2K
J2704	Injection, propofol, 10 mg	<1%	1,047	$2K
73130		<1%	12	$2K
84132		<1%	2,716	$2K
J7510	Prednisolone oral, per 5 mg	<1%	21	$2K
71275	Computed tomographic angiography, chest, with contrast material	<1%	13	$1K
85651		<1%	1,508	$1K
85379		<1%	256	$1K
82270		<1%	168	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,233	$1K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	79	$1K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	250	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	50	$1K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,316	$1K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	84	$1K
82570		<1%	331	$918.50
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	50	$901.36
93017		<1%	14	$764.00
V2632	Posterior chamber intraocular lens	<1%	16	$726.00
84446		<1%	236	$678.38
83605		<1%	1,452	$665.06
80069		<1%	65	$516.19
96367		<1%	166	$492.78
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	15	$466.80
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	448	$450.68
J1094	Injection, dexamethasone acetate, 1 mg	<1%	1,589	$409.29
81015		<1%	3,191	$408.29
80076		<1%	42	$402.01
J1756	Injection, iron sucrose, 1 mg	<1%	36	$402.01
83021		<1%	973	$402.01
76000		<1%	30	$385.80
86901		<1%	992	$380.02
84295		<1%	2,643	$360.38
82550		<1%	867	$324.89
85730		<1%	1,172	$311.57
83615		<1%	797	$290.20
86140		<1%	541	$284.78
82565		<1%	2,088	$205.87
83874		<1%	1,046	$158.14
82728		<1%	787	$71.39
87563		<1%	51	$43.60
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	84	$43.06
86141		<1%	108	$42.00
84100		<1%	752	$40.83
82607		<1%	101	$37.59
82746		<1%	101	$37.59
J2550	Injection, promethazine hcl, up to 50 mg	<1%	79	$26.00
84481		<1%	30	$23.60
85018		<1%	58	$22.09
84479		<1%	72	$18.35
83921		<1%	13	$17.91
82150		<1%	13	$17.73
82043		<1%	37	$13.15
86803		<1%	46	$12.80
94760		<1%	13	$12.19
82947		<1%	2,639	$5.39
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	16	$5.00
87340		<1%	369	$4.80
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	99	$4.15
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	84	$4.00
83655		0%	1,202	$0.00
S0028	Injection, famotidine, 20 mg	0%	100	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	21	$0.00
81513		0%	37	$0.00
87535		0%	52	$0.00
86336		0%	20	$0.00
84156		0%	14	$0.00
84165		0%	12	$0.00
86235		0%	39	$0.00
83540		0%	24	$0.00
S5010	5% dextrose and 0.45% normal saline, 1000 ml	0%	16	$0.00
84155		0%	12	$0.00
84478		0%	685	$0.00
86701		0%	50	$0.00
85660		0%	972	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	170	$0.00
85027		0%	21	$0.00
99213	Doctor's office visit, returning patient (routine)	0%	28	$0.00
86762		0%	98	$0.00
86225		0%	43	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	29	$0.00
82677		0%	19	$0.00
82105		0%	19	$0.00
88304		0%	13	$0.00
87184		0%	15	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	14	$0.00
87522	Neg quan hep c or qual rna	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOMISSIONG, TINA (CEO)